Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Procalcitonin a Valuable Marker for the Identification of Postoperative Complications After Open-heart Surgery With Cardiopulmonary Bypass?

NCT04213040 is registered in ClinicalTrials.gov with Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital as lead sponsor.

NCT NCT04213040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04213040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Procalcitonin a Valuable Marker for the Identification of Postoperative Complications After Open-heart Surgery With Cardiopulmonary Bypass?
Lead sponsor
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2013
Completion date
December 31, 2013
Enrollment
214 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

c-reactive protein, cardiopulmonary bypass, lactate, open heart surgery, outcome, postoperative complications, procalcitonin